Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Market Cap	2.68B
Revenue (ttm)	567.06M
Net Income (ttm)	76.35M
Shares Out	44.93M
EPS (ttm)	1.68
PE Ratio	35.54
Forward PE	n/a
Dividend	1.75 (2.97%)
Ex-Dividend Date	Jun 26, 2025

Volume	14,290
Average Volume	15,893
Open	59.00
Previous Close	59.00
Day's Range	59.00 - 59.70
52-Week Range	56.60 - 88.30
Beta	-0.11
RSI	33.37
Earnings Date	Mar 30, 2026

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was founded...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 171
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2024, TPEX:4747's revenue was 611.42 million, an increase of 0.78% compared to the previous year's 606.71 million. Earnings were 84.12 million, an increase of 5.55%.